USE OF HEDIS A1C TARGETS IN CHARACTERIZING TREATMENT GOALS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING BASAL INSULIN

被引：0

作者：

Oster, G. ^{[1
]}

Moen, D. ^{[2
]}

Yang, T. ^{[3
]}

Dalal, M. ^{[3
]}

Kazemi, M. ^{[3
]}

Sung, J. C. ^{[3
]}

Traylor, L. ^{[3
]}

Sullivan, S. D. ^{[4
]}

机构：

[1] Policy Anal Inc, Brookline, MA USA

[2] MoenMDConsulting, St Paul, MN USA

[3] Sanofi US Inc, Bridgewater, NJ USA

[4] Univ Washington, Sch Pharm, Seattle, WA 98195 USA

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.407

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PDB100

引用

页码：A70 / A70

页数：1

共 50 条

[1] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
Chou, Engels
Dippel, Franz-Werner
Chung, Hsing-Wen
DIABETES, 2014, 63 : A403 - A403
[2] Characteristics of patients with type 2 diabetes mellitus (T2DM) on basal insulin who do not achieve glycaemic goals
Brunton, S.
Blonde, L.
Chava, P.
Zhou, R.
Meyers, J.
Davis, K.
Dalal, M.
DiGenio, A.
DIABETOLOGIA, 2014, 57 : S54 - S54
[3] Comparison of 3 Algorithms for Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus (T2DM)
Dailey, George
Aurand, Lisa
Stewart, John
Ameer, Barbara
Zhou, Rong
DIABETES, 2012, 61 : A263 - A263
[4] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
Martin, Silas C.
Henk, Henry J.
Chow, Wing
DIABETES, 2014, 63 : A307 - A307
[5] Oral Antidiabetic Drug (OAD) and Insulin (I) Treatment Patterns in Treatment Naive Type 2 Diabetes Mellitus (T2DM) Patients with High Baseline (BL) Hemoglobin A1c (A1C)
Krishnarajah, Girishanthy
Amin, Shahla
Balar, Bharvi A.
DIABETES, 2010, 59 : A567 - A567
[6] Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
Halter, Jeffrey B.
Kennedy, Laurence
Herman, William H.
Miller, Michael E.
DIABETES, 2006, 55 : A114 - A115
[7] Glycaemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
Halter, J.
Kennedy, L.
Miller, M.
Herman, W.
DIABETOLOGIA, 2006, 49 : 602 - 603
[8] ADHERENCE AND PERSISTENCE IN PATIENTS INITIATING TREATMENT WITH INJECTABLE THERAPIES FOR TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
Sicras-Mainar, A.
Navarro, R.
Ruiz, L.
Morano, R.
VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
[9] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Blonde, Lawrence
Woo, Vincent
Mathieu, Chantal
Yee, Jacqueline
Vijapurkar, Ujjwala
Meininger, Gary
DIABETES, 2014, 63 : A284 - A284
[10] Risk Factors and Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Basal Insulin in a US Managed Care System
Chou, Engels
Chung, Hsing-Wen
Wang, Hongwei
DIABETES, 2014, 63 : A66 - A67

← 1 2 3 4 5 →